Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1702828 | 0.88 | LCK (0.38) | ALDH1A1HPGDHIF1ALMNACYP3A4 | |
| SCHEMBL1703599 | 0.86 | LCK (0.46) | ALDH1A1LMNACYP3A4NFKB1LCK | |
| SCHEMBL3780560 | 0.84 | LCK (0.48) | ALDH1A1LMNACYP3A4LCKPPARD | |
| SCHEMBL1703313 | 0.84 | LCK (0.48) | ALDH1A1LMNACYP3A4LCKPPARD | |
| SCHEMBL3770475 | 0.82 | — | — | |
| SCHEMBL6350861 | 0.76 | LMNA (0.37) | ALDH1A1LMNATSHRCYP3A4NFKB1 | |
| SCHEMBL6381596 | 0.76 | LMNA (0.37) | ALDH1A1LMNATSHRCYP3A4NFKB1 | |
| SCHEMBL17366581 | 0.76 | LMNA (0.37) | ALDH1A1LMNATSHRCYP3A4NFKB1 | |
| SCHEMBL1703855 | 0.75 | — | — | |
| SCHEMBL6338975 | 0.74 | LMNA (0.40) | ALDH1A1LMNATSHRCYP3A4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2440047-A1 | BROMINATED NITROALKANOL COMPOSITIONS AND THEIR USE AS BIOCIDES | Dow Global Technologies LLC (US) | 2012-04-18 | — | — | EP | claimed |
| US-20100317744-A1 | BROMINATED NITROALKANOL COMPOSITIONS AND THEIR USE AS BIOCIDES | DDP SPECIALTY ELECTRONIC MATERIALS US, LLC. | 2010-12-16 | — | — | US | claimed |
| WO-2010144511-A1 | BROMINATED NITROALKANOL COMPOSITIONS AND THEIR USE AS BIOCIDES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-12-16 | — | — | WO | claimed |
| US-8993638-B2 | Brominated nitroalkanol compositions and their use as biocides | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-03-31 | — | — | US | disclosed |
| US-20100317744-A1 | BROMINATED NITROALKANOL COMPOSITIONS AND THEIR USE AS BIOCIDES | DDP SPECIALTY ELECTRONIC MATERIALS US, LLC. | 2010-12-16 | — | — | US | disclosed |
| US-4576625-A | BROMO-INTRO COMPOUNDS | HULS AKTIENGESELLSCHAFT (DE) | 1986-03-18 | — | — | US | disclosed |
| US-4113444-A | HALONITRO ALCOHOLS | GULF RESEARCH & DEVELOPMENT CO. (US) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317744-A1 | BROMINATED NITROALKANOL COMPOSITIONS AND THEIR USE AS BIOCIDES | BLVRB, BCL2A1, CBR1 | ALDH1A1 814/4885HPGD 994/4885HIF1A 3935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.